vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $93.5M, roughly 1.3× COMSCORE, INC.). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs 3.2%, a 0.1% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -1.5%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $2.9M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 3.8%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
NATR vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $93.5M |
| Net Profit | $4.1M | $3.0M |
| Gross Margin | 72.5% | 41.0% |
| Operating Margin | 4.3% | 7.0% |
| Net Margin | 3.3% | 3.2% |
| Revenue YoY | 4.7% | -1.5% |
| Net Profit YoY | 1379.4% | -3.7% |
| EPS (diluted) | $0.23 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $93.5M | ||
| Q3 25 | $128.3M | $88.9M | ||
| Q2 25 | $114.8M | $89.4M | ||
| Q1 25 | $113.2M | $85.7M | ||
| Q4 24 | $118.2M | $94.9M | ||
| Q3 24 | $114.6M | $88.5M | ||
| Q2 24 | $110.6M | $85.8M | ||
| Q1 24 | $111.0M | $86.8M |
| Q4 25 | $4.1M | $3.0M | ||
| Q3 25 | $5.3M | $453.0K | ||
| Q2 25 | $5.3M | $-9.5M | ||
| Q1 25 | $4.7M | $-4.0M | ||
| Q4 24 | $-321.0K | $3.1M | ||
| Q3 24 | $4.3M | $-60.6M | ||
| Q2 24 | $1.3M | $-1.7M | ||
| Q1 24 | $2.3M | $-1.1M |
| Q4 25 | 72.5% | 41.0% | ||
| Q3 25 | 73.3% | 40.6% | ||
| Q2 25 | 71.7% | 40.6% | ||
| Q1 25 | 72.1% | 39.6% | ||
| Q4 24 | 72.0% | 42.4% | ||
| Q3 24 | 71.3% | 41.2% | ||
| Q2 24 | 71.4% | 39.5% | ||
| Q1 24 | 71.2% | 42.3% |
| Q4 25 | 4.3% | 7.0% | ||
| Q3 25 | 7.0% | 1.9% | ||
| Q2 25 | 3.7% | -1.9% | ||
| Q1 25 | 5.4% | -2.4% | ||
| Q4 24 | 3.8% | 4.1% | ||
| Q3 24 | 4.6% | -67.4% | ||
| Q2 24 | 5.1% | -2.2% | ||
| Q1 24 | 4.2% | -2.2% |
| Q4 25 | 3.3% | 3.2% | ||
| Q3 25 | 4.2% | 0.5% | ||
| Q2 25 | 4.6% | -10.6% | ||
| Q1 25 | 4.2% | -4.7% | ||
| Q4 24 | -0.3% | 3.3% | ||
| Q3 24 | 3.8% | -68.5% | ||
| Q2 24 | 1.2% | -2.0% | ||
| Q1 24 | 2.1% | -1.2% |
| Q4 25 | $0.23 | $9.50 | ||
| Q3 25 | $0.30 | $-0.86 | ||
| Q2 25 | $0.28 | $-2.73 | ||
| Q1 25 | $0.25 | $-1.66 | ||
| Q4 24 | $-0.02 | $-0.47 | ||
| Q3 24 | $0.23 | $-12.79 | ||
| Q2 24 | $0.07 | $-1.19 | ||
| Q1 24 | $0.12 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $23.6M |
| Total DebtLower is stronger | — | $41.5M |
| Stockholders' EquityBook value | $161.6M | $111.4M |
| Total Assets | $261.1M | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $23.6M | ||
| Q3 25 | $95.6M | $26.7M | ||
| Q2 25 | $81.3M | $26.0M | ||
| Q1 25 | $86.5M | $31.0M | ||
| Q4 24 | $84.7M | $29.9M | ||
| Q3 24 | $78.7M | $20.0M | ||
| Q2 24 | $68.7M | $14.7M | ||
| Q1 24 | $77.8M | $18.7M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | — | $41.4M | ||
| Q2 25 | — | $41.3M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $111.4M | ||
| Q3 25 | $166.7M | $-26.3M | ||
| Q2 25 | $163.7M | $-21.7M | ||
| Q1 25 | $167.1M | $-13.5M | ||
| Q4 24 | $161.0M | $-8.3M | ||
| Q3 24 | $162.6M | $-2.7M | ||
| Q2 24 | $156.4M | $45.8M | ||
| Q1 24 | $159.7M | $51.4M |
| Q4 25 | $261.1M | $407.7M | ||
| Q3 25 | $264.8M | $406.9M | ||
| Q2 25 | $254.9M | $415.9M | ||
| Q1 25 | $252.7M | $421.5M | ||
| Q4 24 | $240.9M | $430.2M | ||
| Q3 24 | $245.3M | $412.5M | ||
| Q2 24 | $235.8M | $474.1M | ||
| Q1 24 | $247.3M | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $3.2M |
| Free Cash FlowOCF − Capex | $7.6M | $2.9M |
| FCF MarginFCF / Revenue | 6.1% | 3.1% |
| Capex IntensityCapex / Revenue | 1.9% | 0.3% |
| Cash ConversionOCF / Net Profit | 2.41× | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $3.2M | ||
| Q3 25 | $18.5M | $9.5M | ||
| Q2 25 | $4.3M | $932.0K | ||
| Q1 25 | $2.6M | $9.1M | ||
| Q4 24 | $12.2M | $-10.0M | ||
| Q3 24 | $9.6M | $12.5M | ||
| Q2 24 | $1.3M | $8.7M | ||
| Q1 24 | $2.2M | $6.9M |
| Q4 25 | $7.6M | $2.9M | ||
| Q3 25 | $16.8M | $9.4M | ||
| Q2 25 | $3.0M | $787.0K | ||
| Q1 25 | $1.5M | $8.7M | ||
| Q4 24 | $10.0M | $-10.3M | ||
| Q3 24 | $7.9M | $12.4M | ||
| Q2 24 | $-2.0M | $8.5M | ||
| Q1 24 | $-1.5M | $6.6M |
| Q4 25 | 6.1% | 3.1% | ||
| Q3 25 | 13.1% | 10.5% | ||
| Q2 25 | 2.6% | 0.9% | ||
| Q1 25 | 1.3% | 10.1% | ||
| Q4 24 | 8.5% | -10.8% | ||
| Q3 24 | 6.9% | 14.0% | ||
| Q2 24 | -1.9% | 10.0% | ||
| Q1 24 | -1.4% | 7.6% |
| Q4 25 | 1.9% | 0.3% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 1.2% | 0.2% | ||
| Q1 25 | 1.0% | 0.4% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 3.0% | 0.2% | ||
| Q1 24 | 3.3% | 0.3% |
| Q4 25 | 2.41× | 1.07× | ||
| Q3 25 | 3.46× | 20.96× | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | -3.19× | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
